-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Lyell Immunopharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q2 2024.
- Lyell Immunopharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $8.28M, a 41.8% decline year-over-year.
- Lyell Immunopharma, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $36.4M, a 44.5% decline year-over-year.
- Lyell Immunopharma, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $47.1M, a 42.5% decline from 2022.
- Lyell Immunopharma, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $81.9M, a 31.7% increase from 2021.
- Lyell Immunopharma, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $62.2M, a 87% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)